Glycosphingolipids and their impact on platelet activity in a murine model of fabry disease
Abstract Fabry disease is an X-linked lysosomal storage disorder caused by deficiency of the lysosomal enzyme ⍺-galactosidase-A (⍺-Gal A), resulting in widespread accumulation of terminal galactose-containing glycosphingolipids (GSLs) and the impairment of multiple organ systems. Thrombotic events a...
Saved in:
| Main Authors: | Adam J. Kanack, Eve Prodoehl, Mayumi Ishihara-Aoki, Kazuhiro Aoki, Nancy M. Dahms |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-024-80633-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lysosomal enzyme binding to the cation-independent mannose 6-phosphate receptor is regulated allosterically by insulin-like growth factor 2
by: Richard N. Bohnsack, et al.
Published: (2024-11-01) -
Glycosphingolipid-associated β-1,4 galactosyltransferase is elevated in patients with systemic lupus erythematosus
by: Vignesh Sadras, et al.
Published: (2020-10-01) -
Changes in glycosphingolipid levels in plasma and cerebrospinal fluid of individuals with Lysosomal Free Sialic Acid Storage Disorder
by: Marya S. Sabir, et al.
Published: (2025-01-01) -
Fabry Disease and Early Stroke
by: U. Feldt-Rasmussen
Published: (2011-01-01) -
Algorithm for Investigation of Fabry Disease in Cardiomyopathies
by: Sandra Marques e Silva, et al.
Published: (2024-10-01)